Trinity Biotech (TRIB) Accounts Payables (2009 - 2025)

Trinity Biotech's Accounts Payables history runs 17 years deep, the most recent figure standing at $29.7 million for Q4 2025.

• In Q4 2025, Accounts Payables rose 10.91% year-over-year to $29.7 million; the TTM figure through Dec 2025 stood at $29.7 million (up 10.91% YoY), while the FY2025 annual figure was $29.7 million, up 10.91% from the prior year.
• Accounts Payables came in at $29.7 million for Q4 2025 at Trinity Biotech, up from $26.5 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $30.9 million in Q1 2021 to a low of $12.2 million in Q3 2023.
• A 5-year average of $19.3 million and a median of $17.0 million in 2021 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables slumped 49.36% in 2022 and jumped 109.2% in 2024, its largest moves.
• Trinity Biotech's Accounts Payables stood at $15.1 million in 2021, then increased by 1.64% to $15.4 million in 2022, then declined by 16.73% to $12.8 million in 2023, then surged by 109.2% to $26.8 million in 2024, then increased by 10.91% to $29.7 million in 2025.
• According to Business Quant data, Accounts Payables over the past three periods registered $29.7 million, $26.5 million, and $26.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison